Comparison

PSYCKES vs Viz.ai

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

PSYCKES

This app allows New York State behavioral health providers to search for clients and access critical treatment, service utilization, and care coordination data from their mobile devices. It provides secure access to clinical summaries, safety plans, medication history, and contact information for enhanced patient care.

Highlights
  • Search for Medicaid clients
  • View clinical summaries
  • Access care coordination contacts
  • Review safety plans
  • Track service utilization
  • View medication history
Features
Read full description

Search for clients and view service utilization, treatment data, and care coordination information from the field using your iPhone or iPad. New York State behavioral health providers, care managers, and managed care plans using PSYCKES can now utilize this mobile application to: • Search for a Medicaid client • Enable consent or emergency access to view client’s clinical summary • View care coordination contact information • View safety plans and psychiatric advanced directives • Review outpatient, emergency room, and inpatient medical and behavioral health services • View psychotropic and medical medications picked up at the pharmacy • Access recently viewed clients easily without having to re-enter search criteria You must first be granted access to PSYCKES by your organization before you can use the PSYCKES mobile app. For new PSYCKES users, you must login for the first time on your desktop computer in order to create a PIN before you can login to the PSYCKES mobile app. To learn more about the PSYCKES application visit our website www.psyckes.com Send questions or feedback about the app to us at PSYCKES-Help@omh.ny.gov The following types of New York State organizations are eligible for access to the PSYCKES application: • NYS providers with one or more OMH licensed program(s) • NYS providers with one or more OASAS licensed program(s) • NYS Federally Qualified Health Centers • NYS Health Home Programs • NYS Care Management Programs • Medicaid Managed Care Organizations • NYS OMH Local Government Units

About

Viz.ai

This AI-powered telehealth platform assists clinicians in detecting critical diseases like stroke and hemorrhages using advanced imaging. It automates workflows and provides mobile imaging with HIPAA-compliant messaging to improve care coordination.

Highlights
  • AI-powered disease detection
  • Automated CT perfusion imaging
  • Mobile imaging capabilities
  • HIPAA-compliant messaging
  • Synchronized multi-specialty workflow
  • Remote installation
Features
Read full description

A Telehealth Platform from the World’s Leading AI Healthcare Company. Viz.ai, which uses artificial intelligence to detect diseases like large vessel occlusions and intracerebral hemorrhages, advanced imaging to automate CT perfusion. Viz.ai also provides mobile imaging and HIPAA-compliant messaging to help synchronize workflow across multiple specialties for diseases like stroke. Fast and easy to install remotely, our plug-and-play solution is designed to help clinical teams during these challenging times. Viz LVO, Viz CTP and Viz ICH are regulated as a medical device and intended for use by trained clinicians. Indications for use are available here: https://www.viz.ai/indications-for-use/

Screenshots

PSYCKES4 screens
Viz.ai4 screens

Verdict

The call

The clearest difference is review sentiment: PSYCKES at 89% against Viz.ai's 13%. PSYCKES also leads on rating (4.8 vs 4.2). Viz.ai's advantage is update cadence (fortnightly vs every 4 months) and ratings volume (36 vs 11). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

PSYCKES holds the better App Store score, 4.8 against 4.2. Both are backed by a comparable volume of ratings — 11 and 36 respectively. Written reviews point the same way: 89% of PSYCKES's written reviews are positive against 13% of Viz.ai's.

UpkeepUpdate frequency

PSYCKES ships an update every 4 months, Viz.ai fortnightly. The most recent releases landed on November 16, 2026 and November 19, 2026 respectively.

Scorecard4 real differences · 6 level
PSYCKES versus Viz.ai: the parameters behind the verdict, then further details
ParameterPSYCKESViz.ai
PriceFreeFree
Rating4.8 (11 ratings) — better4.2 (36 ratings)
Positive reviews88.9% of reviews — better12.5% of reviews
Number of ratings1136 — better
Update frequencyEvery 4 monthsFortnightly — better
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPadiPhone, iPad
Requires iOS18.017.0 — better
Further details — not scored
Size33 MB56 MB
Age rating17+12+
DeveloperResearch Foundation for Mental HygieneViz.ai, Inc.

Customer experience

PSYCKES

All ratings11 ratings
Positive90.9%
Neutral9.1%
Negative0.0%
Written reviews9 reviews
Positive88.9%
Neutral11.1%
Negative0.0%

Viz.ai

All ratings36 ratings
Positive77.8%
Neutral2.8%
Negative19.4%
Written reviews8 reviews
Positive12.5%
Neutral0.0%
Negative87.5%

In-app purchases

None

PSYCKES

No in-app purchases

None

Viz.ai

No in-app purchases

Questions

Is PSYCKES free?
PSYCKES is free to download, with no in-app purchases.
Is Viz.ai free?
Viz.ai is free to download, with no in-app purchases.
Which has better reviews, PSYCKES or Viz.ai?
PSYCKES is rated higher. PSYCKES averages 4.8 out of 5 from 11 ratings, while Viz.ai averages 4.2 from 36 ratings.
Do PSYCKES or Viz.ai have ads?
Neither PSYCKES nor Viz.ai shows ads.
Which is updated more often, PSYCKES or Viz.ai?
PSYCKES ships an update every 4 months, and Viz.ai fortnightly. Most recently, PSYCKES was updated on November 16, 2026 and Viz.ai on November 19, 2026.

Other comparisons